Imelda vzw
Hospital
Location:
Bonheiden,
Belgium (BE)
ISNI: 0000000406088744
ROR: https://ror.org/037s71n47
Show on Map:
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024)
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al.
Journal article
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease (2022)
Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Atreya R, et al.
Journal article
Impact of Eligibility Criteria on Clinical Outcomes of Firehawk and XIENCE Coronary Drug-Eluting Stent in an All-Comers Randomized Trial (2019)
Saito Y, Wijns W, Baumbach A, Xu B, Kelbaek H, Van Royen N, Zheng M, et al.
Conference contribution
2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent (2019)
Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, et al.
Journal article
Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY (2018)
Bossuyt P, Atreya R, Taxonera C, Hebuterne X, Isaacs K, Higgins PD, Lindsay J, et al.
Conference contribution